Art

J-GLOBAL ID：201802253339650689   Reference number：18A1913666

Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action

抗動脈硬化作用を超えた高密度リポ蛋白質の心保護作用

Author (5)： Nagao Manabu (Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine) ,  Nakajima Hideto (Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine) ,  Toh Ryuji (Division of Evidence-Based Laboratory Medicine, Kobe University Graduate School of Medicine) ,  Hirata Ken-ichi (Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine) ,  Ishida Tatsuro (Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine)
Material： Journal of Atherosclerosis and Thrombosis (Web)  (J Atheroscler Thromb (Web))
Volume： 25  Issue： 10  Page： 985-993(J-STAGE)  Publication year： 2018 
JST Material Number： U0153A  ISSN： 1880-3873  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *myocardial protective effect ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1913666&from=J-GLOBAL&jstjournalNo=U0153A") }}

Author keywords (6)： High-density lipoprotein ,  Cardioprotective effect ,  Heart failure ,  Fatty acid ,  Endothelial lipase ,  mTOR signal

JST classification (2)： Biological function  (EB03040U) ,  Cardiovascular system diseases  (GJ03000C)

Reference (79)：

• 1) Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, Narula J, Shor ES, Young JB, Hong Y, American Heart Association Council on E, Prevention, American Heart Association Council on Clinical C, American Heart Association Council on Cardiovascular N, American Heart Association Council on High Blood Pressure R, Quality of C, Outcomes Research Interdisciplinary Working G, Functional G and Translational Biology Interdisciplinary Working G. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2008; 117: 2544-2565
• 2) Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S and Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986; 256: 2835-2838
• 3) Assmann G, Schulte H, von Eckardstein A and Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 1996; 124 Suppl: S11-S20
• 4) Curb JD, Abbott RD, Rodriguez BL, Masaki K, Chen R, Sharp DS and Tall AR. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res. 2004; 45: 948-953
• 5) Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W and Atherosclerosis Risk in Communities Study G. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001; 104: 1108-1113

Terms in the title (3)： 抗動脈硬化作用 ,  高密度リポ蛋白質 ,  心保護作用